Showing results (5381-5390 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|November 22, 2017
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid TumorsKeun-Wook Lee, Dae Ho Lee, Jin Hyoung Kang, et al.
The Oncologist|November 22, 2017
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I ResultsEileen M O'Reilly, James Roach, Paul Miller, et al.
The Oncologist|December 8, 2017
The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of BiosimilarsJennifer R Brown, Florence Cymbalista, Jeff Sharman, et al.
The Oncologist|December 8, 2017
Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon-αSmaranda Gazdaru, Lucien Perey, Anne Rosselet, et al.
The Oncologist|December 8, 2017
Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation TherapyWilliam H Sherman, Elizabeth Hecht, David Leung, et al.
The Oncologist|December 10, 2017
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven CasesCostantine Albany, Lawrence Einhorn, Lawrence Garbo, et al.
The Oncologist|January 14, 2018
Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2-Amplified Colorectal CancerMarwan G Fakih
The Oncologist|November 30, 2017
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access ProgramOliver Sartor, Nicholas J Vogelzang, Christopher Sweeney, et al.
The Oncologist|December 16, 2017
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future DirectionsYoung Kwang Chae, Michael S Oh, Francis J Giles
The Oncologist|March 1, 2018
Effect of Concomitant pH-Elevating Medications with Pazopanib on Progression-Free Survival and Overall Survival in Patients with Metastatic Renal Cell CarcinomaRenee K McAlister, Jonathan Aston, Megan Pollack, et al.
Pageof 571